08. Juni 2021 | Hepatitiden
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.
Buggisch P, Heiken H, Mauss S, Weber B, Jung MC, Görne H, Heyne R, Hinrichsen H, Hidde D, König B, Pires Dos Santos AG, Niederau C, Berg...